TumCP Cancer Research Results
TumCP, Tumor Cell proliferation: Click to Expand ⟱
| Source: |
| Type: |
Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors.
|
ESCC, Oesophageal Squamous Cell Carcinoma: Click to Expand ⟱
Esophageal cancer is a growth of cells that starts in the esophagus.
|
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
ESCC, |
TE1 |
|
|
|
- |
vitro+vivo, |
ESCC, |
KYSE-510 |
|
|
|
- |
in-vitro, |
Nor, |
Het-1A |
|
|
|
TumCP↓, LC3‑Ⅱ/LC3‑Ⅰ↑, p62↓, p‑AMPK↑, mTOR↓, TumAuto↑, NCOA4↑, MDA↑, Iron↑, TumW↓, TumVol↓, ATG5↑, ATG7↑, TfR1/CD71↓, FTH1↓, ROS↑, Iron↑, Ferroptosis↑, *toxicity↓,
| - |
vitro+vivo, |
ESCC, |
Eca109 |
|
|
|
tumCV↓, TumCCA↑, ROS↑, TumAuto↑, eff↓, TRF2↓, TumCP↓,
| - |
in-vitro, |
ESCC, |
KYSE150 |
|
|
|
- |
in-vitro, |
ESCC, |
KYSE170 |
|
|
|
TumCP↓, TumMeta↓, Glycolysis↓, N-cadherin↓, PKM2↓, Hif1a↓,
| - |
in-vitro, |
ESCC, |
KYSE150 |
|
|
|
TumCP↓, TumCMig↓, Glycolysis↓, cycD1/CCND1↓, CDK4↓, ECAR↓, TumCCA↑, HK1↓, ALDH↓, ALDOA↓, PKM2↓, Hif1a↓,
| - |
in-vitro, |
ESCC, |
KYSE150 |
|
|
|
TumCP↓, Apoptosis↓, TumCMig↓, TumCCA↑, DNAdam↑, MAPK↓, γH2AX↑, TumMeta↓, TumCI↓, P21↑, ROS↑, EMT↓, ChemoSen↑,
TumCP↓, e-LDH↑, MMP↓, Ca+2?, PFK↓, Glycolysis↓,
| - |
in-vitro, |
ESCC, |
KYSE-30 |
|
|
|
- |
in-vitro, |
ESCC, |
KYSE450 |
|
|
|
TumCP↓, TumCMig↓, TumCI↓, Apoptosis↑, Bcl-2↓, BAX↑, cl‑PARP1↑, cl‑Casp3↑, cl‑Casp9↑, PI3K↓, p‑Akt↓, p‑mTOR↓, PTEN↑,
AntiCan↑, toxicity↓, TumCP↓, Apoptosis↑, TumCCA↑, MMP↓, ROS↑, eff↓, RadioS↑,
| - |
in-vitro, |
ESCC, |
TE1 |
|
|
|
- |
in-vitro, |
ESCC, |
Eca109 |
|
|
|
- |
vitro+vivo, |
SCC, |
KYSE150 |
|
|
|
TumCP↓, TumCMig↓, MMP2↓, Apoptosis↑, cl‑Casp3↑, cl‑Casp9↑, BAX↑, Bcl-2↓, p‑p38↓, TumCG↓,
| - |
in-vitro, |
ESCC, |
KYSE-30 |
|
|
|
Pyro↑, TumCP↓, TumCMig↓, TumCI↓, ASC↑, cl‑Casp1↑, NLRP3↑, GSDMD↑, ROS↑, NRF2↓, TXNIP↑,
TumCP↓, TumCMig↓, PKA↓, GlucoseCon↓, lactateProd↓, PKM2↓, STAT3↓, cMyc↓,
TumCP↓, ROS↑, DNAdam↑,
| - |
in-vitro, |
ESCC, |
KYSE-510 |
|
|
|
- |
in-vitro, |
ESCC, |
Eca109 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
TumCP↓, Glycolysis↓, GlucoseCon↓, lactateProd↓, PKM2↓, p‑PKM2↓, p‑STAT3↓, GLUT1↓, HK2↓, TumW↓,
Showing Research Papers: 1 to 13 of 13
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 13
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Ferroptosis↑, 1, HK1↓, 1, Iron↑, 2, MDA↑, 1, NRF2↓, 1, ROS↑, 6,
Metal & Cofactor Biology ⓘ
FTH1↓, 1, NCOA4↑, 1, TfR1/CD71↓, 1,
Mitochondria & Bioenergetics ⓘ
MMP↓, 2,
Core Metabolism/Glycolysis ⓘ
ALDOA↓, 1, p‑AMPK↑, 1, ATG7↑, 1, cMyc↓, 1, ECAR↓, 1, GlucoseCon↓, 2, Glycolysis↓, 4, HK2↓, 1, lactateProd↓, 2, e-LDH↑, 1, PFK↓, 1, PKM2↓, 4, p‑PKM2↓, 1,
Cell Death ⓘ
p‑Akt↓, 1, Apoptosis↓, 1, Apoptosis↑, 3, BAX↑, 2, Bcl-2↓, 2, cl‑Casp1↑, 1, cl‑Casp3↑, 2, cl‑Casp9↑, 2, Ferroptosis↑, 1, GSDMD↑, 1, MAPK↓, 1, p‑p38↓, 1, Pyro↑, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
Autophagy & Lysosomes ⓘ
ATG5↑, 1, LC3‑Ⅱ/LC3‑Ⅰ↑, 1, p62↓, 1, TumAuto↑, 2,
DNA Damage & Repair ⓘ
DNAdam↑, 2, cl‑PARP1↑, 1, γH2AX↑, 1,
Cell Cycle & Senescence ⓘ
CDK4↓, 1, cycD1/CCND1↓, 1, P21↑, 1, TumCCA↑, 4,
Proliferation, Differentiation & Cell State ⓘ
ALDH↓, 1, EMT↓, 1, mTOR↓, 1, p‑mTOR↓, 1, PI3K↓, 1, PTEN↑, 1, STAT3↓, 1, p‑STAT3↓, 1, TRF2↓, 1, TumCG↓, 1,
Migration ⓘ
Ca+2?, 1, MMP2↓, 1, N-cadherin↓, 1, PKA↓, 1, TumCI↓, 3, TumCMig↓, 6, TumCP↓, 13, TumMeta↓, 2, TXNIP↑, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 2,
Barriers & Transport ⓘ
GLUT1↓, 1,
Immune & Inflammatory Signaling ⓘ
ASC↑, 1,
Protein Aggregation ⓘ
NLRP3↑, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, eff↓, 2, RadioS↑, 1,
Clinical Biomarkers ⓘ
e-LDH↑, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, toxicity↓, 1, TumVol↓, 1, TumW↓, 2,
Total Targets: 79
Pathway results for Effect on Normal Cells:
Functional Outcomes ⓘ
toxicity↓, 1,
Total Targets: 1
Scientific Paper Hit Count for: TumCP, Tumor Cell proliferation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:41 Cells:% prod#:% Target#:327 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page